Central Nervous System Embryonal Tumor clinical trials at UCSF
1 research study open to eligible people
Central Nervous System Embryonal Tumors are a type of brain tumor. UCSF is currently recruiting for a clinical trial called HeadStart4. This trial is for children under 10 years old who have just been diagnosed. There is also another trial in progress but it is not looking for new participants.
open to eligible people ages up to 10 years
This is a prospective randomized clinical trial, to determine whether dose-intensive tandem Consolidation, in a randomized comparison with single cycle Consolidation, provides an event-free survival (EFS) and overall survival (OS). The study population will be high-risk patients (non-Wnt and non-Shh sub-groups) with medulloblastoma, and for all patients with central nervous system (CNS) embryonal tumors completing "Head Start 4" Induction. This study will further determine whether the additional labor intensity (duration of hospitalizations and short-term and long-term morbidities) associated with the tandem treatment is justified by the improvement in outcome. It is expected that the tandem (3 cycles) Consolidation regimen will produce a superior outcome compared to the single cycle Consolidation, given the substantially higher dose intensity of the tandem regimen, without significant addition of either short-term or long-term morbidities.
Oakland, California and other locations
Our lead scientists for Central Nervous System Embryonal Tumor research studies include Caroline Hastings, MD.